https://knews.kathimerini.com.cy/en/news/first-ever-mrna-vaccine-for-lung-cancer-begins-human-trials
Doctors have launched the first clinical trial of an mRNA vaccine designed to treat lung cancer, a groundbreaking step that could significantly impact survival rates....
https://knews.kathimerini.com.cy/en/news/asian-elephant-receives-first-ever-mrna-vaccine-for-deadly-virus
Tess, a 40-year-old Asian elephant at the Houston Zoo, has become the first to receive an mRNA vaccine targeting the lethal elephant endotheliotropic herpesvirus (EEHV). ...
https://knews.kathimerini.com.cy/en/news/moderna-s-combined-covid-flu-vaccine-proves-effective
Moderna's combined COVID-19 and flu vaccine has demonstrated efficacy equivalent to that of separate shots in late-stage trials, according to results published on Monday. ...
https://knews.kathimerini.com.cy/en/business/astrazeneca-requests-withdrawal-of-european-authorization-for-covid-19-vaccine
Pharmaceutical giant AstraZeneca has formally requested the European Medicines Agency (EMA) to withdraw the European authorization for its COVID-19 vaccine, Vaxzevria, as confirmed by the EU medicines regulator....
https://knews.kathimerini.com.cy/en/news/vaccine-triggers-robust-immune-response-against-brain-cancer
In groundbreaking trials, scientists have unveiled a pioneering mRNA cancer vaccine, igniting a robust immune response to combat deadly brain tumors. ...
https://knews.kathimerini.com.cy/en/news/eu-commission-president-affirms-support-for-cyprus
In a recent interview commemorating the 20th anniversary of the 2004 enlargement of the EU, Commission President Ursula von der Leyen spoke to Kathimerini reporter Geroger Kakouris and expressed unwavering support for Cyprus in its ongoing issues, emphasizing the EU's solidarity with the country. ...
https://knews.kathimerini.com.cy/en/news/new-vaccine-shows-promise-against-deadly-skin-cancer
In a groundbreaking development in cancer treatment, doctors are conducting trials on what could be the world’s first personalized mRNA vaccine against melanoma, marking a potential game-changer in the fight against cancer....
https://knews.kathimerini.com.cy/en/news/international-study-finds-potential-adverse-effects-from-covid-vaccines
A recent study examining nearly 100 million vaccinated individuals across eight countries reaffirmed the known links between COVID-19 vaccines and certain adverse effects....
https://knews.kathimerini.com.cy/en/news/covid-19-novavax-vaccine-now-available-for-18-and-older
As of Thursday 21/12/2023, the Nuvaxovid HBV.1.5 COVID-19 vaccine by Novavax will be available for people over 18 years of age, the Ministry of Health said in a statement....
https://knews.kathimerini.com.cy/en/news/nobel-prize-honors-pioneers-of-mrna-vaccine-technology
The Nobel Prize in Physiology or Medicine has been awarded to a pair of scientists who developed the technology that led to the mRNA Covid vaccines.
...
https://knews.kathimerini.com.cy/en/news/new-covid-vaccine-meets-eris-variant-challenge
A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from "Eris", a variant of the Omicron form of the coronavirus, rise around the country....
https://knews.kathimerini.com.cy/en/news/revolutionary-mrna-vaccine-boosts-skin-cancer-treatment-by-65
In a mid-stage trial, Moderna Inc and Merck & Co announced on Monday that the addition of their experimental mRNA-based vaccine has shown a 65% reduction in the risk of spreading the deadliest form of skin cancer when used in combination with immunotherapy alone....
https://knews.kathimerini.com.cy/en/news/eu-health-commissioner-to-visit-vaccine-production-plant-in-south-africa
EU Commissioner for Health Stella Kyriakides will visit a vaccine production plant and an mRNA technology hub whilst in South Africa. She will be in the country from Thursday to Saturday,...
https://knews.kathimerini.com.cy/en/news/covid-cyprus-transitioning-to-endemic-period
If the current decline in the number of COVID-19 cases worldwide continues, this means we will transit to the endemic period of the pandemic, Dr. Petros Karayiannis,...
https://knews.kathimerini.com.cy/en/news/moderna-sues-pfizer-for-patent-infringement
Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," the company said in a news release Friday....
https://knews.kathimerini.com.cy/en/news/coronavirus-inhaled-vaccines-offer-better-protection-and-immunity
Canadian scientists comparing two different alternative vaccine delivery systems confirmed that inhaled aerosol vaccines provide better protection and stronger immunity than nasal spray vaccines....
https://knews.kathimerini.com.cy/en/news/seniors-in-cyprus-remain-skeptical-of-fourth-shot
A spectacularly small number of people over 60 got their fourth COVID jab so far in the Republic of Cyprus, with the health ministry contemplating to lower the age threshold at a time while medical experts advocating for the vaccine are jumping ship on the immunity debate...
https://knews.kathimerini.com.cy/en/news/study-heart-inflammation-more-prevalent-among-vaccinated-than-unvaccinated
Heart inflammation requiring hospital care was more common among people who received COVID-19 vaccines than those who did not, according to a new study of tens of millions of Europeans....
https://knews.kathimerini.com.cy/en/news/a-third-dose-is-recommended-for-children-over-12-a-fourth-to-the-more-vulnerable
In its efforts to protect the most vulnerable from covid, the National Advisory Committee on vaccines and the Ministry of Health are recommending the following:...
https://knews.kathimerini.com.cy/en/news/covid-boosters-continue-to-protect-most-people-for-many-months-perhaps-years
According to a flurry of new studies, it looks as if Covid boosters will continue to protect most people from serious illness and death for many months, and perhaps even years — which means we probably won’t need to line up for another shot anytime soon....
https://knews.kathimerini.com.cy/en/news/who-is-dr-robert-malone-and-what-is-the-controversy-surrounding-his-statements-on-mrna-vaccines
Robert Malone, the self-proclaimed inventor of mRNA vaccines and a skeptic of the COVID-19 vaccines that use mRNA technology, has skyrocketed to celebrity status in recent months....
https://knews.kathimerini.com.cy/en/news/nasal-spray-could-be-the-future-of-the-covid-vaccine
When we think about COVID vaccines, most of us picture a pointy needle — and some of us might even faint. But what if getting vaccinated was as easy as inhaling a nasal spray?...
https://knews.kathimerini.com.cy/en/news/op-ed-the-far-reaching-benefits-of-mrna-technology
The mRNA platform is a tantalizingly simple and transformative technology, scaling the scope of targeting diseases in ways that were previously unimaginable....
https://knews.kathimerini.com.cy/en/news/first-batches-of-novavax-to-arrive-this-month-in-greece
Greece plans to start administering the Novavax protein vaccine against SARS-CoV-2 in early March, General Secretary of Primary Healthcare Marios Themistokleous said Tuesday....
https://knews.kathimerini.com.cy/en/news/novavax-could-offer-the-unvaccinated-a-new-option-if-regulators-agree
Following a long-awaited submission of data to the Food and Drug Administration last month, Novavax announced Monday that it had formally filed a request for emergency use authorization of its protein-based COVID-19 vaccine in the United States....
https://knews.kathimerini.com.cy/en/business/anti-vaxxers-making-‘at-least-$2-5m-a-year-from-publishing-on-substack
A group of vaccine-sceptic writers are generating revenues of at least $2.5m (£1.85m) a year from publishing newsletters for tens of thousands of followers on the online publishing platform Substack, according to new research....
https://knews.kathimerini.com.cy/en/news/halting-progress-and-happy-accidents-how-mrna-vaccines-were-made
Skeptics have seized on the rapid development of the vaccines to undermine the public’s trust in them. But the breakthroughs behind the vaccines unfolded over decades as scientists across the world pursued research in disparate areas, never imagining their work would one day come together to tame the pandemic of the century....
https://knews.kathimerini.com.cy/en/news/full-vaccination-plus-breakthrough-infection-equals-super-immunity
A study by Oregon researchers finds that people fully vaccinated against COVID-19 who have a breakthrough infection end up with what the authors call "super immunity."...
https://knews.kathimerini.com.cy/en/news/booster-shots-for-18-and-over-begins-wednesday
The vaccination portal will now be available from the 8th of December for people aged 18 and over to book booster shot appointments. ...
https://knews.kathimerini.com.cy/en/news/third-dose-for-30-and-over
The vaccination portal will now be available from the 30th of November for people aged 30 and up to book booster shot appointments....
